Literature DB >> 7058051

The management of meibomian gland carcinoma.

J T Harvey, R L Anderson.   

Abstract

We present nine cases of sebaceous adenocarcinoma seen on the Oculoplastic Service at the University of Iowa over the past five years. It is essential to make the biopsy-proven diagnosis of meibomian gland adenocarcinoma promptly, using multiple full thickness eyelid biopsies. We recommend the Mohs' fresh-frozen technique in patients with surgically resectable lesions, exenteration in those with orbital extension, and radical neck dissection for cases with nodal involvement. Radiotherapy may be indicated in patients with extensive tumors who cannot tolerate or refuse surgery or as an adjunct to surgery in others.

Entities:  

Mesh:

Year:  1982        PMID: 7058051

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  5 in total

1.  Sebaceous carcinoma of the eyelid: a rarity worth considering.

Authors:  Alexander Gardetto; Christian Rainer; Christian Ensinger; Ivo Baldissera; Hildegunde Piza-Katzer
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Sebaceous carcinoma of eyelid.

Authors:  Manoranjan Varshney; Kiran Alam; Mehar Aziz; Veena Maheshwari; Kavita Gaur; SyedAli Raza Rizvi
Journal:  BMJ Case Rep       Date:  2011-06-21

3.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

4.  A case of giant advanced sebaceous gland carcinoma.

Authors:  Deevish Dinakar; Rajashekara Babu; Sadashivaiah Shivaswamy
Journal:  Indian J Surg Oncol       Date:  2013-07-14

5.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.